Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05755750

Intratendinous Genipin Injection in Horses With Tendon Injuries

Conditions: Superficial Digital Flexor Tendonitis

Sex: All
Phase: PHASE3
Enrollment: 74
Sponsor: University of Zurich

Location: Switzerland

Summary

Our study is the first to use genipin, a naturally occurring collagen cross-linking agent, as a therapeutic agent to treat superficial digital flexor tendon (SDFT) injuries in horses. The promising approach of intratendinous genipin injection and tendon mechanical enhancement could be a viable alternative to current therapies for SDFT injuries.

Eligibility Criteria

Inclusion Criteria:clinical and sonographic evidence of a tendon injuryExclusion Criteria:in the final analysis, only superficial digital flexor tendon injuries were includedif follow-up was less than 12 m due to euthanasia, death or other reasons, horses were excluded from the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05755750). StuddyBuddy aggregates publicly available trial information.